Search research articles
Contact Us
Filters
Showing results (291-300 of 408) with videos related to
Page
of 41
Sort By:
Plos One
|
January 27, 2016
Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India
Sunil S Solomon, Aylur K Srikrishnan, Allison M McFall, et al.
Hepatology (Baltimore, Md.)
|
April 8, 2014
Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients
Ashwin Balagopal, Abraham J Kandathil, Yvonne H Higgins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 15, 2016
Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies
Christoph Sarrazin, Vasily Isakov, Evguenia S Svarovskaia, et al.
JAMA
|
July 24, 2012
Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV
Berkeley N Limketkai, Shruti H Mehta, Catherine G Sutcliffe, et al.
Journal of Viral Hepatitis
|
February 4, 2016
Public health clinic-based hepatitis C testing and linkage to care in Baltimore
O Falade-Nwulia, S H Mehta, J Lasola, et al.
Journal of Viral Hepatitis
|
July 19, 2017
Directly observed therapy of sofosbuvir/ribavirin +/- peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT)
S S Solomon, M S Sulkowski, P Amrose, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 13, 2016
Short-duration treatment for chronic hepatitis C virus with daclatasvir, asunaprevir, beclabuvir and sofosbuvir (FOURward study)
Mark S Sulkowski, Steve Flamm, Zeid Kayali, et al.
AIDS (London, England)
|
December 20, 2007
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults
Mark S Sulkowski, Shruti H Mehta, Michael S Torbenson, et al.
The Journal of Infectious Diseases
|
September 18, 2013
Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study
Mark S Sulkowski, Minhee Kang, Roy Matining, et al.
Hepatitis Research and Treatment
|
October 25, 2012
Hepatitis C virus: a critical appraisal of new approaches to therapy
David R Nelson, Donald M Jensen, Mark S Sulkowski, et al.
Page
of 41
Search research articles
Search
Showing results (291-300 of 408) with videos related to
Sort By:
Page
of 41
Plos One
|
January 27, 2016
Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India
Sunil S Solomon, Aylur K Srikrishnan, Allison M McFall, et al.
Hepatology (Baltimore, Md.)
|
April 8, 2014
Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients
Ashwin Balagopal, Abraham J Kandathil, Yvonne H Higgins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 15, 2016
Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies
Christoph Sarrazin, Vasily Isakov, Evguenia S Svarovskaia, et al.
JAMA
|
July 24, 2012
Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV
Berkeley N Limketkai, Shruti H Mehta, Catherine G Sutcliffe, et al.
Journal of Viral Hepatitis
|
February 4, 2016
Public health clinic-based hepatitis C testing and linkage to care in Baltimore
O Falade-Nwulia, S H Mehta, J Lasola, et al.
Journal of Viral Hepatitis
|
July 19, 2017
Directly observed therapy of sofosbuvir/ribavirin +/- peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT)
S S Solomon, M S Sulkowski, P Amrose, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 13, 2016
Short-duration treatment for chronic hepatitis C virus with daclatasvir, asunaprevir, beclabuvir and sofosbuvir (FOURward study)
Mark S Sulkowski, Steve Flamm, Zeid Kayali, et al.
AIDS (London, England)
|
December 20, 2007
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults
Mark S Sulkowski, Shruti H Mehta, Michael S Torbenson, et al.
The Journal of Infectious Diseases
|
September 18, 2013
Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study
Mark S Sulkowski, Minhee Kang, Roy Matining, et al.
Hepatitis Research and Treatment
|
October 25, 2012
Hepatitis C virus: a critical appraisal of new approaches to therapy
David R Nelson, Donald M Jensen, Mark S Sulkowski, et al.
Page
of 41